ASND•benzinga•
Ascendis Presents Long-Term Data In Adult Patients With Hypoparathyroidism Treated With TransCon PTH through Week 110 In The PaTH Forward Trial Presented At ASBMR
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 12, 2022 by benzinga